Clinical trial

OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa

NCT06967519

Study summary

ClinicalTrials.gov

OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Artemether-lumefantrine (AL) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention artesunate-amodiaquine (AS-AQ) Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-12-18

PhasePHASE4

Conditions

Malariaverified · MONDO: malaria

Hivunresolved

Interventions

Artemether-lumefantrine (AL)DRUG

artesunate-amodiaquine (AS-AQ)DRUG

Sponsors & collaborators

Yale Universitylead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Mapped research locations

KampalaUganda2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06967519 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.